UV Cleavable Biotin-PEG2-Azide-13C

Catalog No. :
ACSXYJ691
CAS No. :
1654739-36-2
Molecular Formula :
C38H51N7O9S
Molecular Weight :
787.89

IUPAC Name:1-(3-((2,13-dioxo-17-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-6,9-dioxa-3,12-diazaheptadecyl)oxy)phenyl)-2-oxo-2-phenylethyl 6-azidohexanoate-1,2,3,4,5,6-13C6

UV Cleavable Biotin-PEG2-Azide-13C structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameUV Cleavable Biotin-PEG2-Azide-13C
IUPAC Name1-(3-((2,13-dioxo-17-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-6,9-dioxa-3,12-diazaheptadecyl)oxy)phenyl)-2-oxo-2-phenylethyl 6-azidohexanoate-1,2,3,4,5,6-13C6
Molecular FormulaC38H51N7O9S
Molecular Weight787.89
SMILES[N-]=[N+]=N[13CH2][13CH2][13CH2][13CH2][13CH2][13C](=O)OC(C(=O)C1=CC=CC=C1)C1=CC=CC(OCC(=O)NCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)=C1
InChI KeyJHYKDGNZEADRIH-DAXKULNWSA-N
SynonymUV Cleavable Biotin-PEG2-Azide;JZN 39362;Hexanoic-1,2,3,4,5,6-13C6 acid, 6-azido-, 1-[3-[[17-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-2,13-dioxo-6,9-dioxa-3,12-diazaheptadec-1-yl]oxy]phenyl]-2-oxo-2-phenylethyl ester
CAS No.1654739-36-2

Synthetic Route by SureRoute

1. ACSXYJ691 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSXYJ691 route product structure diagram
    ACSXYJ6911654739-36-2
Inquiry

2. ACSXYJ691 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBWUK036 route compound structure diagram
    ACBWUK03658-85-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSXYJ691 route product structure diagram
    ACSXYJ6911654739-36-2
Inquiry

Comments (0)